Cargando…
Reply to T. Hasegawa et al and I. Gross et al
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477934/ https://www.ncbi.nlm.nih.gov/pubmed/27507880 http://dx.doi.org/10.1200/JCO.2016.68.7681 |
_version_ | 1783244871165804544 |
---|---|
author | Leyland-Jones, Brian Vercammen, Els Xiu, Liang |
author_facet | Leyland-Jones, Brian Vercammen, Els Xiu, Liang |
author_sort | Leyland-Jones, Brian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5477934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-54779342017-06-29 Reply to T. Hasegawa et al and I. Gross et al Leyland-Jones, Brian Vercammen, Els Xiu, Liang J Clin Oncol Correspondence American Society of Clinical Oncology 2016-11-01 2016-08-08 /pmc/articles/PMC5477934/ /pubmed/27507880 http://dx.doi.org/10.1200/JCO.2016.68.7681 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Correspondence Leyland-Jones, Brian Vercammen, Els Xiu, Liang Reply to T. Hasegawa et al and I. Gross et al |
title | Reply to T. Hasegawa et al and I. Gross et al |
title_full | Reply to T. Hasegawa et al and I. Gross et al |
title_fullStr | Reply to T. Hasegawa et al and I. Gross et al |
title_full_unstemmed | Reply to T. Hasegawa et al and I. Gross et al |
title_short | Reply to T. Hasegawa et al and I. Gross et al |
title_sort | reply to t. hasegawa et al and i. gross et al |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477934/ https://www.ncbi.nlm.nih.gov/pubmed/27507880 http://dx.doi.org/10.1200/JCO.2016.68.7681 |
work_keys_str_mv | AT leylandjonesbrian replytothasegawaetalandigrossetal AT vercammenels replytothasegawaetalandigrossetal AT xiuliang replytothasegawaetalandigrossetal |